0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.36%
Revenue growth 1.25-1.5x ECL.AX's 4.11%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
15.75%
Gross profit growth above 1.5x ECL.AX's 4.55%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
34.85%
EBIT growth above 1.5x ECL.AX's 6.50%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
34.85%
Operating income growth above 1.5x ECL.AX's 6.50%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-100.00%
Negative net income growth while ECL.AX stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-100.00%
Negative EPS growth while ECL.AX is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-100.00%
Negative diluted EPS growth while ECL.AX is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
69.26%
Share count expansion well above ECL.AX's 22.86%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
46.43%
Diluted share count expanding well above ECL.AX's 22.86%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-23.93%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
5424.68%
10Y revenue/share CAGR above 1.5x ECL.AX's 236.11%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
No Data
No Data available this quarter, please select a different quarter.
-89.62%
Negative 3Y CAGR while ECL.AX stands at 90.78%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
95.16%
10Y OCF/share CAGR under 50% of ECL.AX's 1643.93%. Michael Burry would worry about a persistent underperformance in cash creation.
No Data
No Data available this quarter, please select a different quarter.
-123.87%
Negative 3Y OCF/share CAGR while ECL.AX stands at 51.37%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Net income/share CAGR of 100.00% while ECL.AX is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-85.69%
We cut SG&A while ECL.AX invests at 5.64%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.